Back

Primary prevention of sudden cardiac death in patients with tetralogy of Fallot with implantable cardioverter defibrillator: insights from the DAI-T4F study

3 September 2019 (11:36 - 11:45)
Organised by:
Congress Presentation Part of: Prognosis, identification & treatment of ventricular arrhythmia Device Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Victor Waldmann

European Hospital Georges Pompidou, Paris (France)

9 More presentations in this session

Presentation thumbnail
Incidental Ventricular Tachycardia: Short and Long-term Prognosis
Doctor A. Sajadieh (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Intra-cardiac thrombus in patients undergoing ventricular tachycardia ablation. a computed tomographic scan study
Professor F. Sacher (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Zero- or near-zero-fluoroscopy radiofrequency catheter ablation for aortic sinus cusp idiopathic ventricular arrhythmias
Associate Professor S. Stec (Cracow, PL)
Abstract Slides Video
Presentation thumbnail
Ablation of scar-related ventricular tachycardia: paced electrogram feature analysis (PEFA) is a novel and effective substrate based strategy
Doctor D. Crinion (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic predictors of appropriate implantable cardioverter defibrillator therapies in patients with tetralogy of Fallot
Doctor G. Duthoit (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis, identification & treatment of ventricular arrhythmia

The Event

Event poster

ESC Congress 2019

3 September 2019 11:36 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Session
The storm will pass…
thumbnail
Congress Session
Ventricular tachycardia ablation in challenging scenarios: case-based management strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources